Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

There will be scheduled maintenance work beginning on Saturday 15th June 2019 at 8:30 am through to Sunday 16th June 2019 at 11:30 pm (BST).

During this time our website may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.

Issue 4, 2018
Previous Article Next Article

Revisiting amino acids and peptides as anti-glycation agents

Author affiliations


The importance of controlling or preventing protein glycation cannot be overstated and is of prime importance in the treatment of diabetes and associated complications including Alzheimer's disease, cataracts, atherosclerosis, kidney aliments among others. In this respect, simple molecules such as amino acids and peptides hold much promise both in terms of ease and scale-up of synthesis as well as in relation to negligible/low associated toxicity. In view of this, a comprehensive account of literature reports is presented, that documents the anti-glycation activity of natural and non-natural amino acids and peptides. This review also discusses the chemical reactions involved in glycation and the formation of advanced glycation end-products (AGEs) and possible/probable intervention sites and mechanism of action of the reported amino acids/peptides. This aspect of amino acids/peptides adds to their growing importance in medicinal and therapeutic applications.

Graphical abstract: Revisiting amino acids and peptides as anti-glycation agents

Back to tab navigation

Publication details

The article was received on 10 Oct 2017, accepted on 09 Feb 2018 and first published on 12 Feb 2018

Article type: Review Article
DOI: 10.1039/C7MD00514H
Med. Chem. Commun., 2018,9, 614-624

  •   Request permissions

    Revisiting amino acids and peptides as anti-glycation agents

    H. Chilukuri, M. J. Kulkarni and M. Fernandes, Med. Chem. Commun., 2018, 9, 614
    DOI: 10.1039/C7MD00514H

Search articles by author